Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Fiserv Converts Your Neighbourhood Credit Union to DNA

Business Wire December 11, 2014

Research and Markets: Global In Vitro Fertilization (IVF) & Male and Female Fertility Treatment Market, 2014 - 2020

Business Wire December 11, 2014

Global Microscopy (Semiconductor, Life Science, Nanotechnology) Market - Forecast to 2019

PR Newswire December 11, 2014

BlueData Grows Big Data Partner Ecosystem

Marketwired December 11, 2014

DataSift Adds Disqus and Edgar Online to Its Growing Ecosystem of Social Networks and Content Publishers

PR Newswire December 11, 2014

Syros Pharmaceuticals Presents New Data from Its Gene Control Platform at Oncology Conferences

Business Wire December 11, 2014

Syros Pharmaceuticals Announces New Research Published on CDK7 in Lung and Pediatric Cancers

Business Wire December 11, 2014

Galena Biopharma Presents HER2 Screening Data Including Preliminary Leica Bond Oracle(TM) Results From the Phase 3 NeuVax(TM) (nelipepimut-S) Clinical Trial at the 2014 San Antonio Breast Cancer Symposium (SABCS)

GlobeNewswire December 11, 2014

NovoPath Announces Support for OpenText RightFax Express Faxing Solution

PR Newswire December 11, 2014

PetLife Announces Positive Developments in Special Letter to Shareholders

Accesswire December 11, 2014

FuelCell Energy Reaches Industry Milestone of Three Billion Kilowatt Hours of Fuel Cell Power Generation Benefiting Public Health on Three Continents

GlobeNewswire December 11, 2014

Regen BioPharma Presented Novel Therapeutic Target for Leukemia and Myelodysplastic Syndrome at the American Society of Hematology Annual Meeting

Marketwired December 11, 2014

GENiSYSS LLC to Exhibit at 2015 International CES, Booth 75011 Eureka Park, Jan. 6 - 9, 2015, in Las Vegas, NV, US

Business Wire December 11, 2014

Arca biopharma Announces Activation of First Canadian Genetic-AF Clinical Trial Site

Business Wire December 11, 2014

X-Chem and Alexion Collaborate to Discover Novel Therapeutic Candidates to Treat Patients with Severe and Ultra-Rare Disorders

Business Wire December 11, 2014

S&W Elects Mark Wong to its Board

PR Newswire December 11, 2014

Karyopharm Initiates Third Registration-Directed Clinical Trial of Oral Selinexor (KPT-330)

GlobeNewswire December 11, 2014

Amarantus Appoints Elise Brownell, Ph.D., as Senior Vice President of Operations and Project Management

GlobeNewswire December 11, 2014

Pathway Genomics Adds The Honorable Dan Glickman, Former US Cabinet Member and Member of Congress, to Strategic Advisory Board

Business Wire December 11, 2014

Alnylam and The Medicines Company Announce Initiation of Phase 1 Clinical Trial for ALN-PCSsc, a Subcutaneously Administered Investigational RNAi Therapeutic Targeting PCSK9 for the Treatment of Hypercholesterolemia

Business Wire December 11, 2014